221 related articles for article (PubMed ID: 25787809)
21. EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.
Berardelli A; Wenning GK; Antonini A; Berg D; Bloem BR; Bonifati V; Brooks D; Burn DJ; Colosimo C; Fanciulli A; Ferreira J; Gasser T; Grandas F; Kanovsky P; Kostic V; Kulisevsky J; Oertel W; Poewe W; Reese JP; Relja M; Ruzicka E; Schrag A; Seppi K; Taba P; Vidailhet M
Eur J Neurol; 2013 Jan; 20(1):16-34. PubMed ID: 23279440
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of Cardiac MIBG Scintigraphy, Olfactory Testing and Substantia Nigra Hyperechogenicity as Additional Diagnostic Markers for Distinguishing between Parkinson's Disease and Atypical Parkinsonian Syndromes.
Fujita H; Suzuki K; Numao A; Watanabe Y; Uchiyama T; Miyamoto T; Miyamoto M; Hirata K
PLoS One; 2016; 11(11):e0165869. PubMed ID: 27812167
[TBL] [Abstract][Full Text] [Related]
23. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
[TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
[TBL] [Abstract][Full Text] [Related]
25. Substantia nigra hyperechogenicity does not correlate with motor features in Parkinson's disease.
Jesus-Ribeiro J; Sargento-Freitas J; Sousa M; Silva F; Freire A; Januário C
J Neurol Sci; 2016 May; 364():9-11. PubMed ID: 27084206
[TBL] [Abstract][Full Text] [Related]
26. Hyperechogenicity of the substantia nigra in Parkinson's disease.
Ressner P; Skoloudík D; Hlustík P; Kanovský P
J Neuroimaging; 2007 Apr; 17(2):164-7. PubMed ID: 17441838
[TBL] [Abstract][Full Text] [Related]
27. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.
Sommer U; Hummel T; Cormann K; Mueller A; Frasnelli J; Kropp J; Reichmann H
Mov Disord; 2004 Oct; 19(10):1196-202. PubMed ID: 15390014
[TBL] [Abstract][Full Text] [Related]
28. Is transcranial sonography useful for diagnosing Parkinson's disease in clinical practice?
Grippe TC; Allam N; Brandão PRP; Pereira DA; Cardoso FEC; Aguilar ACR; Kessler IM
Arq Neuropsiquiatr; 2018 Jul; 76(7):459-466. PubMed ID: 30066797
[TBL] [Abstract][Full Text] [Related]
29. The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study.
Gaenslen A; Unmuth B; Godau J; Liepelt I; Di Santo A; Schweitzer KJ; Gasser T; Machulla HJ; Reimold M; Marek K; Berg D
Lancet Neurol; 2008 May; 7(5):417-24. PubMed ID: 18394965
[TBL] [Abstract][Full Text] [Related]
30. Olfactory function distinguishes vascular parkinsonism from Parkinson's disease.
Katzenschlager R; Zijlmans J; Evans A; Watt H; Lees AJ
J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1749-52. PubMed ID: 15548497
[TBL] [Abstract][Full Text] [Related]
31. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
[TBL] [Abstract][Full Text] [Related]
32. [Transcranial sonography in Parkinson's disease].
Fedotova EIu; Chechetkin AO; Shadrina MI; Slominskiĭ PA; Ivanova-Smolenskaia IA; Illarioshkin SN
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):49-55. PubMed ID: 21350412
[TBL] [Abstract][Full Text] [Related]
33. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
[TBL] [Abstract][Full Text] [Related]
34. Ultrasonographic (TCS) and clinical findings in overlapping phenotype of essential tremor and Parkinson's disease (ET-PD).
Laučkaitė K; Rastenytė D; Šurkienė D; Vaidelytė B; Dambrauskaitė G; Sakalauskas A; Vaitkus A; Gleiznienė R
BMC Neurol; 2014 Mar; 14():54. PubMed ID: 24655437
[TBL] [Abstract][Full Text] [Related]
35. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
[TBL] [Abstract][Full Text] [Related]
36. Use of smell test identification in Parkinson's disease in Mexico: a matched case-control study.
Rodríguez-Violante M; Lees AJ; Cervantes-Arriaga A; Corona T; Silveira-Moriyama L
Mov Disord; 2011 Jan; 26(1):173-6. PubMed ID: 20842690
[TBL] [Abstract][Full Text] [Related]
37. Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.
Laučkaitė K; Rastenytė D; Šurkienė D; Vaitkus A; Sakalauskas A; Lukoševičius A; Gleiznienė R
BMC Neurol; 2012 Mar; 12():12. PubMed ID: 22400906
[TBL] [Abstract][Full Text] [Related]
38. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson's disease: A Systematic Review and Meta-analysis.
Li DH; He YC; Liu J; Chen SD
Sci Rep; 2016 Feb; 6():20863. PubMed ID: 26878893
[TBL] [Abstract][Full Text] [Related]
40. A clinical approach towards smell loss in Parkinson's disease.
Haehner A; Hummel T; Reichmann H
J Parkinsons Dis; 2014; 4(2):189-95. PubMed ID: 24322062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
